lymphoma
发表于 2025-3-25 03:30:02
https://doi.org/10.1007/978-4-431-68219-6ity of tumor is high. One of the principal causes of this situation is the lack of clinical prognostic biomarkers, useful for the diagnostic and therapeutic monitoring and for the definition of personalized treatments that could lead to improvement in the therapeutic success rate..In the neoplastic
flavonoids
发表于 2025-3-25 09:24:33
https://doi.org/10.1007/978-4-431-68219-6mune memory. Targeting major histocompatibility complex (MHC) class I and class II epitopes and multiple tumor antigens has met with some clinical success, which is advantageous over single epitope vaccine strategies. Moreover, cancer immunotherapy and peptide therapeutics especially have demonstrat
摘要
发表于 2025-3-25 12:35:50
http://reply.papertrans.cn/23/2212/221128/221128_23.png
茁壮成长
发表于 2025-3-25 15:51:16
http://reply.papertrans.cn/23/2212/221128/221128_24.png
DUST
发表于 2025-3-25 20:47:36
http://reply.papertrans.cn/23/2212/221128/221128_25.png
敏捷
发表于 2025-3-26 03:58:55
http://reply.papertrans.cn/23/2212/221128/221128_26.png
联想
发表于 2025-3-26 08:03:18
https://doi.org/10.1007/978-1-4419-1676-1 for hematologic malignancies and, more recently, has shown efficacy for the treatment of solid tumors. Destruction of hematopoietic cells through myeloablative or non-myeloablative “conditioning” serves to eliminate or reduce numbers of malignant cells, create “space” in the hematopoietic compartme
Airtight
发表于 2025-3-26 08:55:41
http://reply.papertrans.cn/23/2212/221128/221128_28.png
Flounder
发表于 2025-3-26 12:45:18
http://reply.papertrans.cn/23/2212/221128/221128_29.png
Nomogram
发表于 2025-3-26 16:58:01
Optical medical diagnostics and imaging,hem attractive targets for cancer immunotherapy, namely, their MHC-unrestricted recognition of tumors, potent cytotoxicity, and abundant production of interferon-γ (IFN-γ) and tumor necrosis factor (TNF). Moreover, seminal work with mice genetically deficient for γδ T cells has clearly shown they co